Context Therapeutics Inc (CNTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $15.24M
Last updated: Nov 17, 2026 at 4:41 PM ET
Context Therapeutics Inc (CNTX) Statistics
Context Therapeutics (CNTX) has a market cap of $15.24M. It holds $34.41M more cash than debt, 225.75% of its market cap.
Total Valuation
| Market Cap | $15.24M |
|---|---|
| Latest price (Nov 17, 2026) | $0.17 |
Key Dates
The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 85.26% over 52 weeks and trades 39.29% below its 50-day average.
| Beta (1Y) | 0.38 |
|---|---|
| 52-Week Change | -85.26% |
| 1-Month Change | -28.27% |
| 3-Month Change | -64.92% |
| 6-Month Change | -92.12% |
| 5-Year Change | -96.72% |
| Total Return (1Y) | -85.26% |
| Total Return (3Y CAGR) | -44.49% |
| Total Return (5Y CAGR) | -47.91% |
| Max Drawdown (1Y) | -95.06% |
| Max Drawdown (3Y) | -95.06% |
| Sharpe Ratio (1Y) | -1.57 |
| Correlation with SPY (1Y) | 0.04 |
| 50-Day Average | $0.28 |
| 200-Day Average | $1.35 |
| 52-Week Range | $0.16 to $3.62 |
| RSI (14 Days) | 33.6 |
| Average Volume (20 Days) | 1.64M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 6.59x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 6.59x |
|---|---|
| Quick Ratio | 6.59x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -141.55% over the last 12 months, against a 5-year average of -70.80%.
| Return on Equity (ROE) | -141.55% |
|---|---|
| Return on Assets (ROA) | -120.12% |
| ROE (5Y Average) | -70.80% |
| ROA (5Y Average) | -57.73% |
| ROIC (5Y Average) | -51.60% |
Scores
CNTX has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$32.28K |
| Operating Income | -$46.08M |
| Pretax Income | -$43.89M |
| Net Income | -$43.89M |
| Reported EPS (TTM) | -$0.46 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 84.87% of the $36.54M in total assets.
| Cash and Equivalents | $34.41M |
|---|---|
| Total Debt | $0 |
| Net Cash | $34.41M |
| Net Cash Per Share | $0.36 |
| Working Capital | $30.77M |
| Shareholder Equity | $31.01M |
| Book Value Per Share | $0.33 |
| Total Assets | $36.54M |
| Total Liabilities | $5.53M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$33.97M |
|---|---|
| FCF Per Share | -$0.37 |
| Depreciation and Amortization | $132.98K |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -5.91% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -5.91% |
Dividends and Yields
CNTX does not pay a dividend.
| Buyback Yield | 0.00% |
|---|---|
| Shareholder Yield | 0.00% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CNTX
What is CNTX's market cap?
Context Therapeutics has a market cap of $15.24M.
How many shares of CNTX are outstanding?
Context Therapeutics has 95.18M shares outstanding. The count is up 0.00% from a year earlier.
Does CNTX pay a dividend?
No. Context Therapeutics does not pay a dividend.
How much debt does CNTX have?
Context Therapeutics has $0 of total debt and $34.41M of cash and equivalents, a net cash position of $34.41M.
CNTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors